Merrimack Pharmaceuticals, Inc. (MACK) stock prices updated...
 

Merrimack Pharmaceuticals, Inc. stock price

Merrimack Pharmaceuticals, Inc. latest news:


  • 10/30/2017 05:05:05

    BRIEF-Merrimack receives orphan drug designation for MM-121 for the treatment of type of lung cancer

    Merrimack Pharmaceuticals Inc(MACK). * Merrimack receives orphan drug designation for MM-121 for the treatment of heregulin positive non-small cell lung cancer.

  • More trends:

    Merus Labs International Inc.MSLI | Mesa Laboratories, Inc.MLAB | Meta Financial Group, Inc.CASH | Metabolix, Inc.MBLX | Methanex CorporationMEOH | METHES ENERGIES INTERNATIONAL LTDMEIL | METHES ENERGIES INTERNATIONAL LTDMEILW | METHES ENERGIES INTERNATIONAL LTDMEILZ | Metro Bancorp, IncMETR | MFRI, Inc.MFRI |